自拟中风补血引接方对急性缺血性脑血管病患者血清血栓素B2及6-酮前列腺素F1α的影响

摘要

目的：观察自拟中风补血引接方对急性缺血性脑血管病(AICD)患者血清血栓素B2(TXB2)及6-酮前列腺素F1α(6-Keto-PGF1α)的影响,初步探讨中风补血引接方治疗AICD的机制。方法将符合纳入标准的90例AICD病患者随机分为试验组和对照组各45例。对照组予西医常规治疗,试验组在此基础上加服中风补血接引方,每日1剂。2组均治疗7d。治疗前后采用脑卒中临床神经功能缺损程度评分量表进行神经功能缺损评分,判断临床疗效；分别于治疗前及治疗第3、7日空腹静脉采血,检测TXB2及6-Keto-PGF1α含量。结果治疗第7日,2组患者神经功能缺损评分均较治疗前明显降低(P＜0.01),试验组明显低于对照组(P＜0.05)；治疗组总有效率(93.30%)优于对照组(84.40%),差异有统计学意义(P＜0.05)。治疗第3日,2组患者血清TBX2水平及TXB2/6-Keto-PGF1α(T/P)值较治疗前明显降低(P＜0.01),6-Keto-PGF1α显著增高(P＜0.01)；第7日2组患者血清TXB2水平及T/P值较第3日明显降低(P＜0.01),6-Keto-PGF1α显著增高(P＜0.01),第3、7日试验组血清TXB2水平及T/P值低于对照组(P＜0.01),6-Keto-PGF1α高于对照组(P＜0.01,P＜0.05)。结论抑制血小板过度活化、调节T/P失调是中风补血引接方治疗AICD的作用机制之一。%Objective To investigate the effects of prescription of nourishing blood and stretching of stoke (PNBSS) on the levels of TXB2 and 6-Keto-PGF1αin serum of patients with acute ischemic cerebrovascular disease (AICD);To discuss its action mechanism in AICD treatment. Methods Ninety patients with AICD were randomly divided into trial group and control group, 45 cases in each group. The control group received western routine treatment, while the trail group received the western routine treatment plus PNBSS, one dose per day, for one week. Rating scale of neurologic deficit was employed to evaluate treatment effectiveness. Venous blood was collected before the treatment and on the 3rd and 7th days of treatment. Levels of TXB2 and 6-Keto-PGF1αin serum were detected respectively. Results The score of neurologic deficit of post-treatment in two groups apparently decreased compared with baseline (P<0.01), and score of neurologic deficit in trial group on 7th day was lower than that of control group (P<0.05). The total effective rate in trial group was 93.3%, which was apparently higher than that of control group (84.4%). The level of TXB2 in serum and ratio of TXB2/6-Keto-PGF1α (T/P) in two groups on 3rd and 7th days remarkably decreased compared with baseline (P<0.01), while the level of 6-Keto-PGF1α in two groups on 3rd and 7th days was higher than that of baseline (P<0.01). Meanwhile, the level of TXB2 and ratio of T/P in two groups on 7th day were apparently lower than that of 3rd day (P<0.01), and the level of 6-Keto-PGF1αon 7th day was higher than that of 3rd day (P<0.01). The level of TXB2 in serum and ratio of T/P on 3rd and 7th days in trial group were apparently lower than that of control group (P<0.01, P<0.05), while the level of 6-Keto-PGF1α on 3rd and 7th days in trial group was apparently higher than that of control group (P<0.01, P<0.05). Conclusion One of the mechanisms of PNBSS for AICD appears to inhibit overavtivity of thrombocyte, and regulate the misadjustment of ratio of T/P.